Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (1): 5-8    DOI: 10.31083/j.ceog.2021.01.2144
Review Previous articles | Next articles
Adenomyosis – Is a new treatment solution available?
Wu Shun Felix Wong1, *(), Xiao-Gang Zhu2, Min Xue2
1School of Women's and Children's Health, The University of New South Wales, 2921-2999 NSW, Australia
2Department of Gynecology, the Third Xiangya Hospital of Central South University, 410000 Changsha, P. R. China
Download:  PDF(161KB)  ( 113 ) Full text   ( 49 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Adenomyosis is increasingly common up to 20% to 30% of reproductive-aged women who present with menorrhagia, dysmenorrhoea, infertility, and related pregnancy complications. It is often diagnosed by the clinical symptoms and ultrasound examinations. MRI, if available, will give a more detailed confirmation of adenomyosis. There are many medical treatments available for adenomyosis, e.g., oral contraceptives, LNG-IUS, GnRH-a, and progestin, while surgery is often either conservative adenomyomectomy or hysterectomy. All these treatments either impact on the fertility of these patients or not readily accepted by them because of the invasiveness of the surgery and side effects of medication. High Intensity Focused Ultrasound (HIFU) ablation treatment discussed in the paper offers an alternative non-invasive treatment for adenomyosis. The early results of HIFU ablation are satisfactory and well accepted by patients. However, long term follows up, with a combination of medical treatments after HIFU ablation, may offer a new treatment solution for adenomyosis.
Key words:  Adenomyomsis      HIFU      Medical treatment      Adenomyomectomy     
Submitted:  14 May 2020      Revised:  21 June 2020      Accepted:  15 July 2020      Published:  15 February 2021     
*Corresponding Author(s):  Wu Shun Felix Wong     E-mail:  fwong3@hotmail.com.hk

Cite this article: 

Wu Shun Felix Wong, Xiao-Gang Zhu, Min Xue. Adenomyosis – Is a new treatment solution available?. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 5-8.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2021.01.2144     OR     https://ceog.imrpress.com/EN/Y2021/V48/I1/5

[1] Jae-Seong Lee, Tae-Eung Kim, Jang Heub Kim, Byung Joon Park. Unintended pregnancies with term delivery following ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation of uterine fibroid and adenomyosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 842-844.
[2] K. Caliskan. The use of percutaneous cholecystostomy in the treatment of acute cholecystitis during pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 11-13.
No Suggested Reading articles found!